Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys

BACKGROUND: Rwanda was the first African country to implement national human papillomavirus (HPV) vaccination (against types HPV6, 11, 16, and 18). In 2011, a school-based catch-up programme was initiated to vaccinate girls aged younger than 15 years but it also reached older girls in schools. We ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayinzoga, Felix, Tenet, Vanessa, Heideman, Daniëlle A M, Sibomana, Hassan, Umulisa, Marie-Chantal, Franceschi, Silvia, Hakizimana, Jean de Dieu, Clifford, Gary M, Baussano, Iacopo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282073/
https://www.ncbi.nlm.nih.gov/pubmed/37207683
http://dx.doi.org/10.1016/S2214-109X(23)00193-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282073/
https://www.ncbi.nlm.nih.gov/pubmed/37207683
http://dx.doi.org/10.1016/S2214-109X(23)00193-6

Ejemplares similares